Regina Schlaeger1, Nico Papinutto2, Alyssa H Zhu2, Iryna V Lobach3, Carolyn J Bevan2, Monica Bucci2, Antonella Castellano2, Jeffrey M Gelfand2, Jennifer S Graves2, Ari J Green4, Kesshi M Jordan5, Anisha Keshavan5, Valentina Panara2, William A Stern2, H-Christian von Büdingen2, Emmanuelle Waubant2, Douglas S Goodin2, Bruce A C Cree2, Stephen L Hauser2, Roland G Henry6. 1. Department of Neurology, University of California, San Francisco2Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland. 2. Department of Neurology, University of California, San Francisco. 3. Department of Neurology, University of California, San Francisco3Departments of Epidemiology and Biostatistics, University of California, San Francisco. 4. Department of Neurology, University of California, San Francisco4Department of Ophthalmology, University of California, San Francisco. 5. Department of Neurology, University of California, San Francisco5Bioengineering Graduate Group, University of California, San Francisco and Berkeley. 6. Department of Neurology, University of California, San Francisco5Bioengineering Graduate Group, University of California, San Francisco and Berkeley6Department of Radiology and Biomedical Imaging, University of California, San Francisco.
Abstract
IMPORTANCE: In multiple sclerosis (MS), upper cervical cord gray matter (GM) atrophy correlates more strongly with disability than does brain or cord white matter (WM) atrophy. The corresponding relationships in the thoracic cord are unknown owing to technical difficulties in assessing GM and WM compartments by conventional magnetic resonance imaging techniques. OBJECTIVES: To investigate the associations between MS disability and disease type with lower thoracic cord GM and WM areas using phase-sensitive inversion recovery magnetic resonance imaging at 3 T, as well as to compare these relationships with those obtained at upper cervical levels. DESIGN, SETTING, AND PARTICIPANTS: Between July 2013 and March 2014, a total of 142 patients with MS (aged 25-75 years; 86 women) and 20 healthy control individuals were included in this cross-sectional observational study conducted at an academic university hospital. MAIN OUTCOMES AND MEASURES: Total cord areas (TCAs), GM areas, and WM areas at the disc levels C2/C3, C3/C4, T8/9, and T9/10. Area differences between groups were assessed, with age and sex as covariates. RESULTS: Patients with relapsing MS (RMS) had smaller thoracic cord GM areas than did age- and sex-matched control individuals (mean differences [coefficient of variation (COV)]: 0.98 mm2 [9.2%]; P = .003 at T8/T9 and 0.93 mm2 [8.0%]; P = .01 at T9/T10); however, there were no significant differences in either the WM area or TCA. Patients with progressive MS showed smaller GM areas (mean differences [COV]: 1.02 mm2 [10.6%]; P < .001 at T8/T9 and 1.37 mm2 [13.2%]; P < .001 at T9/T10) and TCAs (mean differences [COV]: 3.66 mm2 [9.0%]; P < .001 at T8/T9 and 3.04 mm2 [7.2%]; P = .004 at T9/T10) compared with patients with RMS. All measurements (GM, WM, and TCA) were inversely correlated with Expanded Disability Status Scale score. Thoracic cord GM areas were correlated with lower limb function. In multivariable models (which also included cord WM areas and T2 lesion number, brain WM volumes, brain T1 and fluid-attenuated inversion recovery lesion loads, age, sex, and disease duration), cervical cord GM areas had the strongest correlation with Expanded Disability Status Scale score followed by thoracic cord GM area and brain GM volume. CONCLUSIONS AND RELEVANCE: Thoracic cord GM atrophy can be detected in vivo in the absence of WM atrophy in RMS. This atrophy is more pronounced in progressive MS than RMS and correlates with disability and lower limb function. Our results indicate that remarkable cord GM atrophy is present at multiple cervical and lower thoracic levels and, therefore, may reflect widespread cord GM degeneration.
IMPORTANCE: In multiple sclerosis (MS), upper cervical cord gray matter (GM) atrophy correlates more strongly with disability than does brain or cord white matter (WM) atrophy. The corresponding relationships in the thoracic cord are unknown owing to technical difficulties in assessing GM and WM compartments by conventional magnetic resonance imaging techniques. OBJECTIVES: To investigate the associations between MS disability and disease type with lower thoracic cord GM and WM areas using phase-sensitive inversion recovery magnetic resonance imaging at 3 T, as well as to compare these relationships with those obtained at upper cervical levels. DESIGN, SETTING, AND PARTICIPANTS: Between July 2013 and March 2014, a total of 142 patients with MS (aged 25-75 years; 86 women) and 20 healthy control individuals were included in this cross-sectional observational study conducted at an academic university hospital. MAIN OUTCOMES AND MEASURES: Total cord areas (TCAs), GM areas, and WM areas at the disc levels C2/C3, C3/C4, T8/9, and T9/10. Area differences between groups were assessed, with age and sex as covariates. RESULTS:Patients with relapsing MS (RMS) had smaller thoracic cord GM areas than did age- and sex-matched control individuals (mean differences [coefficient of variation (COV)]: 0.98 mm2 [9.2%]; P = .003 at T8/T9 and 0.93 mm2 [8.0%]; P = .01 at T9/T10); however, there were no significant differences in either the WM area or TCA. Patients with progressive MS showed smaller GM areas (mean differences [COV]: 1.02 mm2 [10.6%]; P < .001 at T8/T9 and 1.37 mm2 [13.2%]; P < .001 at T9/T10) and TCAs (mean differences [COV]: 3.66 mm2 [9.0%]; P < .001 at T8/T9 and 3.04 mm2 [7.2%]; P = .004 at T9/T10) compared with patients with RMS. All measurements (GM, WM, and TCA) were inversely correlated with Expanded Disability Status Scale score. Thoracic cord GM areas were correlated with lower limb function. In multivariable models (which also included cord WM areas and T2 lesion number, brain WM volumes, brain T1 and fluid-attenuated inversion recovery lesion loads, age, sex, and disease duration), cervical cord GM areas had the strongest correlation with Expanded Disability Status Scale score followed by thoracic cord GM area and brain GM volume. CONCLUSIONS AND RELEVANCE: Thoracic cord GM atrophy can be detected in vivo in the absence of WM atrophy in RMS. This atrophy is more pronounced in progressive MS than RMS and correlates with disability and lower limb function. Our results indicate that remarkable cord GM atrophy is present at multiple cervical and lower thoracic levels and, therefore, may reflect widespread cord GM degeneration.
Authors: Christopher P Gilmore; Gabriele C DeLuca; Lars Bö; Trudy Owens; James Lowe; Margaret M Esiri; Nikos Evangelou Journal: Brain Pathol Date: 2008-12-19 Impact factor: 6.508
Authors: Iñigo Gabilondo; Elena H Martínez-Lapiscina; Eloy Martínez-Heras; Elena Fraga-Pumar; Sara Llufriu; Santiago Ortiz; Santiago Bullich; Maria Sepulveda; Carles Falcon; Joan Berenguer; Albert Saiz; Bernardo Sanchez-Dalmau; Pablo Villoslada Journal: Ann Neurol Date: 2014-01-02 Impact factor: 10.422
Authors: L J Balk; M D Steenwijk; P Tewarie; M Daams; J Killestein; M P Wattjes; H Vrenken; F Barkhof; C H Polman; B M J Uitdehaag; A Petzold Journal: J Neurol Neurosurg Psychiatry Date: 2014-06-27 Impact factor: 10.154
Authors: Massimiliano Calabrese; Roberta Magliozzi; Olga Ciccarelli; Jeroen J G Geurts; Richard Reynolds; Roland Martin Journal: Nat Rev Neurosci Date: 2015-03 Impact factor: 34.870
Authors: J P Klein; A Arora; M Neema; B C Healy; S Tauhid; D Goldberg-Zimring; C Chavarro-Nieto; J M Stankiewicz; A B Cohen; G J Buckle; M K Houtchens; A Ceccarelli; E Dell'Oglio; C R G Guttmann; D C Alsop; D B Hackney; R Bakshi Journal: AJNR Am J Neuroradiol Date: 2011-04-28 Impact factor: 3.825
Authors: E Raz; M Bester; E E Sigmund; A Tabesh; J S Babb; H Jaggi; J Helpern; R J Mitnick; M Inglese Journal: AJNR Am J Neuroradiol Date: 2013-04-11 Impact factor: 3.825
Authors: Valentina Panara; R Navarra; P A Mattei; E Piccirilli; V Bartoletti; A Uncini; M Caulo Journal: Neuroradiology Date: 2018-12-05 Impact factor: 2.804
Authors: Noriko Isobe; Anisha Keshavan; Pierre-Antoine Gourraud; Alyssa H Zhu; Esha Datta; Regina Schlaeger; Stacy J Caillier; Adam Santaniello; Antoine Lizée; Daniel S Himmelstein; Sergio E Baranzini; Jill Hollenbach; Bruce A C Cree; Stephen L Hauser; Jorge R Oksenberg; Roland G Henry Journal: JAMA Neurol Date: 2016-07-01 Impact factor: 18.302
Authors: D B McCoy; J F Talbott; Michael Wilson; M D Mamlouk; J Cohen-Adad; Mark Wilson; J Narvid Journal: AJNR Am J Neuroradiol Date: 2016-12-15 Impact factor: 3.825
Authors: Riley Bove; Tanuja Chitnis; Bruce Ac Cree; Mar Tintoré; Yvonne Naegelin; Bernard Mj Uitdehaag; Ludwig Kappos; Samia J Khoury; Xavier Montalban; Stephen L Hauser; Howard L Weiner Journal: Mult Scler Date: 2017-08-29 Impact factor: 6.312
Authors: V Panara; R Navarra; P A Mattei; E Piccirilli; A R Cotroneo; N Papinutto; R G Henry; A Uncini; M Caulo Journal: Neuroradiology Date: 2017-07-04 Impact factor: 2.804
Authors: Leah A Davis; Mohammed S Alenazy; Awad M Almuklass; Daniel F Feeney; Taian Vieira; Alberto Botter; Roger M Enoka Journal: J Neurophysiol Date: 2020-04-29 Impact factor: 2.714
Authors: Nico Papinutto; Carlo Asteggiano; Antje Bischof; Tristan J Gundel; Eduardo Caverzasi; William A Stern; Stefano Bastianello; Stephen L Hauser; Roland G Henry Journal: J Neuroimaging Date: 2019-09-30 Impact factor: 2.486